Select Committee · Health and Social Care Committee

Future cancer

Status: Closed Opened: 21 Mar 2023 Closed: 30 May 2024

The Future Cancer inquiry will explore innovations in cancer diagnosis and treatment. It will look at the innovations with the greatest potential to transform cancer diagnosis and treatment for patients in the short, medium and long term, and it will examine how innovations in diagnosing and treating cancer can best be transitioned into frontline clinical … Show more

Oral evidence sessions

6 sessions
Date Witnesses
29 Jan 2024 Dame Cally Palmer · NHS England, Professor Peter Johnson · NHS England, Rt Hon Andrew Stephenson · Department of Health and Social Care View ↗
9 Jan 2024 Dr Julie Gralow · American Society of Clinical Oncology, Dr Paul Mullholland · University College London and University College London Hospitals, Professor David Baldwin · School of Medicine (University of Nottingham), Professor David Chang · University of Glasgow, Professor Mark Lawler · Queen's Univeristy Belfast View ↗
28 Nov 2023 James Hargrave · Keep Up With Cancer, Julian Beach · Medicines and Healthcare products Regulatory Agency (MHRA), Professor Paul Dalby · University College London, Sarah Byron · National Institute for Health and Care Excellence (NICE), Tony Hickson · Cancer Research Horizons and Cancer Research UK View ↗
14 Sep 2023 Dr Robin Buckle · Medical Research Council, Dr Susan Galbraith · AstraZeneca, Professor Kevin Harrington · Institute of Cancer Research, Professor Sir John Bell · Oxford University View ↗
19 Jul 2023 Marcel Gehrung, PhD · Cyted, Professor Matt Brown · Genomics England, Professor Stephen Duffy · Wolfson Institute of Population Health (Queen Mary University of London), Sara Hiom · GRAIL Europe View ↗
21 Jun 2023 Anna Jewell · Less Survivable Cancers Taskforce, Gemma Peters · Macmillan Cancer Support, Jane Lyons · Cancer52, Michelle Mitchell OBE · Cancer Research UK View ↗

Who gave evidence

25 witnesses
WitnessOrganisationSessions
Anna Jewell · Chair Less Survivable Cancers Taskforce 1
Dame Cally Palmer · National Cancer Director NHS England 1
Dr Julie Gralow · Executive Vice President and Chief Medical Officer American Society of Clinical Oncology 1
Dr Paul Mullholland · Honorary Associate Professor and Consultant in me… University College London and University College London Hospitals 1
Dr Robin Buckle · Chief Science Officer Medical Research Council 1
Dr Susan Galbraith · Executive Vice President of Oncology Research & D… AstraZeneca 1
Gemma Peters · Chief Executive Officer Macmillan Cancer Support 1
James Hargrave · Vice-Chair Keep Up With Cancer 1
Jane Lyons · Chief Executive Officer Cancer52 1
Julian Beach · Interim Executive Director, Healthcare Quality an… Medicines and Healthcare products Regulatory Agency (MHRA) 1
Marcel Gehrung, PhD · Co-founder and Chief Executive Officer Cyted 1
Michelle Mitchell OBE · Chief Executive Officer Cancer Research UK 1
Professor David Baldwin · Consultant Respiratory Physician and Honorary Pro… School of Medicine (University of Nottingham) 1
Professor David Chang · Co-Lead of Precision-Panc, and Chair of Surgical … University of Glasgow 1
Professor Kevin Harrington · Head of the Division of Radiotherapy and Imaging Institute of Cancer Research 1
Professor Mark Lawler · Board Member (European Cancer Organisation), and … Queen's Univeristy Belfast 1
Professor Matt Brown · Chief Scientific Officer Genomics England 1
Professor Paul Dalby · Co-Director of the Future Targeted Healthcare Man… University College London 1
Professor Peter Johnson · National Clinical Director for Cancer NHS England 1
Professor Sir John Bell · Regius Professor of Medicine Oxford University 1
Professor Stephen Duffy · Professor of Cancer Screening Wolfson Institute of Population Health (Queen Mary University of London) 1
Rt Hon Andrew Stephenson · Minister of State (Minister for Health and Second… Department of Health and Social Care 1
Sara Hiom · Vice President, NHS Implementation & External… GRAIL Europe 1
Sarah Byron · Programme Director of Devices, Diagnostics and Di… National Institute for Health and Care Excellence (NICE) 1
Tony Hickson · Chief Business Officer Cancer Research Horizons and Cancer Research UK 1

Correspondence

1 letter
DateDirectionTitle
28 May 2024 Chair to Secretary of State for Health and Social Care on Future Cancer 23.05.24